297 related articles for article (PubMed ID: 23775726)
1. SUMO and ischemic tolerance.
Lee YJ; Hallenbeck JM
Neuromolecular Med; 2013 Dec; 15(4):771-81. PubMed ID: 23775726
[TBL] [Abstract][Full Text] [Related]
2. Global protein conjugation by ubiquitin-like-modifiers during ischemic stress is regulated by microRNAs and confers robust tolerance to ischemia.
Lee YJ; Johnson KR; Hallenbeck JM
PLoS One; 2012; 7(10):e47787. PubMed ID: 23094087
[TBL] [Abstract][Full Text] [Related]
3. Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells.
Lee YJ; Miyake S; Wakita H; McMullen DC; Azuma Y; Auh S; Hallenbeck JM
J Cereb Blood Flow Metab; 2007 May; 27(5):950-62. PubMed ID: 16955077
[TBL] [Abstract][Full Text] [Related]
4. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
[TBL] [Abstract][Full Text] [Related]
5. Elevated global SUMOylation in Ubc9 transgenic mice protects their brains against focal cerebral ischemic damage.
Lee YJ; Mou Y; Maric D; Klimanis D; Auh S; Hallenbeck JM
PLoS One; 2011; 6(10):e25852. PubMed ID: 22016779
[TBL] [Abstract][Full Text] [Related]
6. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
7. Hypophosphorylation of ribosomal protein S6 is a molecular mechanism underlying ischemic tolerance induced by either hibernation or preconditioning.
Miyake S; Wakita H; Bernstock JD; Castri P; Ruetzler C; Miyake J; Lee YJ; Hallenbeck JM
J Neurochem; 2015 Dec; 135(5):943-57. PubMed ID: 26375300
[TBL] [Abstract][Full Text] [Related]
8. Transient global cerebral ischemia induces a massive increase in protein sumoylation.
Yang W; Sheng H; Warner DS; Paschen W
J Cereb Blood Flow Metab; 2008 Feb; 28(2):269-79. PubMed ID: 17565359
[TBL] [Abstract][Full Text] [Related]
9. SUMOylation participates in induction of ischemic tolerance in mice.
Zhang H; Huang D; Zhou J; Yue Y; Wang X
Brain Res Bull; 2019 Apr; 147():159-164. PubMed ID: 30807794
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells.
Huang CH; Yang TT; Lin KI
J Biomed Sci; 2024 Jan; 31(1):16. PubMed ID: 38280996
[TBL] [Abstract][Full Text] [Related]
11. Moderate hypothermia induces protein SUMOylation in bone marrow stromal cells and enhances their tolerance to hypoxia.
Ren W; Ma X; Liu X; Li Y; Jiang Z; Zhao Y; Li C; Li X
Mol Med Rep; 2017 Nov; 16(5):7006-7012. PubMed ID: 28901483
[TBL] [Abstract][Full Text] [Related]
12. Neuron-specific SUMO knockdown suppresses global gene expression response and worsens functional outcome after transient forebrain ischemia in mice.
Zhang L; Liu X; Sheng H; Liu S; Li Y; Zhao JQ; Warner DS; Paschen W; Yang W
Neuroscience; 2017 Feb; 343():190-212. PubMed ID: 27919694
[TBL] [Abstract][Full Text] [Related]
13. Hibernation reduces cellular damage caused by warm hepatic ischemia-reperfusion in ground squirrels.
Otis JP; Pike AC; Torrealba JR; Carey HV
J Comp Physiol B; 2017 May; 187(4):639-648. PubMed ID: 28144740
[TBL] [Abstract][Full Text] [Related]
14. Ubc9 overexpression and SUMO1 deficiency blunt inflammation after intestinal ischemia/reperfusion.
Karhausen J; Bernstock JD; Johnson KR; Sheng H; Ma Q; Shen Y; Yang W; Hallenbeck JM; Paschen W
Lab Invest; 2018 Jun; 98(6):799-813. PubMed ID: 29472640
[TBL] [Abstract][Full Text] [Related]
15. SUMOylation participates in induction of ischemic tolerance.
Lee YJ; Castri P; Bembry J; Maric D; Auh S; Hallenbeck JM
J Neurochem; 2009 Apr; 109(1):257-67. PubMed ID: 19200349
[TBL] [Abstract][Full Text] [Related]
16. Identification of biochemically distinct properties of the small ubiquitin-related modifier (SUMO) conjugation pathway in Plasmodium falciparum.
Reiter K; Mukhopadhyay D; Zhang H; Boucher LE; Kumar N; Bosch J; Matunis MJ
J Biol Chem; 2013 Sep; 288(39):27724-36. PubMed ID: 23943616
[TBL] [Abstract][Full Text] [Related]
17. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
[TBL] [Abstract][Full Text] [Related]
18. Sumo-2/3-ylation following in vitro modeled ischemia is reduced in delayed ischemic tolerance.
Loftus LT; Gala R; Yang T; Jessick VJ; Ashley MD; Ordonez AN; Thompson SJ; Simon RP; Meller R
Brain Res; 2009 May; 1272():71-80. PubMed ID: 19332039
[TBL] [Abstract][Full Text] [Related]
19. Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function.
He X; Lai Q; Chen C; Li N; Sun F; Huang W; Zhang S; Yu Q; Yang P; Xiong F; Chen Z; Gong Q; Ren B; Weng J; Eizirik DL; Zhou Z; Wang CY
Diabetologia; 2018 Apr; 61(4):881-895. PubMed ID: 29299635
[TBL] [Abstract][Full Text] [Related]
20. SUMO: getting it on.
Anckar J; Sistonen L
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
